ALOX15 Aggravates Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice with Type 2 Diabetes via Activating the PPARγ/CD36 Axis
Antioxidants & Redox Signaling · 2025
DOI: 10.1089/ars.2024.0670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2025. Verfasst von Wenhui Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: PPAR gamma, Arachidonate 15-Lipoxygenase, CD36 Antigens, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
- Institute of Cardiovascular Sciences, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
- Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China.
- Biomedical Experimental Center of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Clinical Medicine, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
- International Obesity and Metabolic Disease Research Center (IIOMC), Xi'an Jiaotong University, Xi'an, Shaanxi, China.
ORCID-Profile: Lina Chen
Zitieren
APA
Yan, W., Cui, X., Guo, T., Liu, N., Wang, Z., Sun, Y., Shang, Y., Liu, J., Zhu, Y., Zhang, Y., & Chen, L. (2025). ALOX15 Aggravates Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice with Type 2 Diabetes via Activating the PPARγ/CD36 Axis. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2024.0670
Vancouver
Yan W, Cui X, Guo T, Liu N, Wang Z, Sun Y, et al. ALOX15 Aggravates Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice with Type 2 Diabetes via Activating the PPARγ/CD36 Axis. Antioxidants & Redox Signaling. 2025. doi:10.1089/ars.2024.0670
BibTeX
@article{Yan2025,
author = {Yan, Wenhui and Cui, Xin and Guo, Tingli and Liu, Na and Wang, Zhuanzhuan and Sun, Yuzhuo and Shang, Yuanrui and Liu, Jieyun and Zhu, Yuanyuan and Zhang, Yangyang and Chen, Lina},
title = {ALOX15 Aggravates Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice with Type 2 Diabetes via Activating the PPARγ/CD36 Axis},
journal = {Antioxidants & Redox Signaling},
year = {2025},
doi = {10.1089/ars.2024.0670}
}
EUVIMED